Researchers explore possible effects in the brainContinue reading
Category Archives: AZBio News
Price controls proposed in the Build Back Better Act – and the recent Reconciliation package – will strike a huge blow to patient access.
New analysis shows that under such policies only 6 of 110 currently approved therapies would have made it to the market because companies would no longer have the necessary funds to invest in research and development and innovative partnerships with small biotech.
Further, the proposed legislation will also likely lead to the loss of over 590,000 US biopharma jobs.Continue reading
Following nature’s rules, researchers develop new methods for treating degenerative neurological disease
The University of Arizona has licensed the new class of drugs designed to penetrate the blood-brain barrier to startup Teleport Pharmaceuticals.Continue reading
ASU scientists find molecular clues behind traumatic brain injury
New research led by scientists at Arizona State University has revealed some of the first detailed molecular clues associated with one of the leading causes of death and disability, a condition known as traumatic brain injury (TBI). Continue reading
Arizona Business Leaders Reach Out In Support of SBIR/STTR Reauthorization
Forty-eight Arizona business leaders signed on to a letter delivered on July 22, 2022 to Arizona’s Congressional Delegation emphasizing the importance of reauthorizing the SBIR/STTR program.
The letter, was signed by business leaders from: Arizona Bioindustry Association, Inc. (AZBio), Arizona Chamber of Commerce & Industry, Arizona Commerce Authority, Arizona Technology Council, Desert Angels, Inc., Greater Phoenix Chamber, Greater Phoenix Economic Council, Greater Phoenix Leadership, PHX East Valley Partnership, Southern Arizona Leadership Council (SALC), Tucson Metro Chamber, UAVenture Capital, University of Arizona, AdviNow Medical, Aesthetics Biomedical, Inc., Aqualung Therapeutics, Anuncia Medical, Inc., Beacon Biomedical, Becton Dickinson (BD), Biosensing Instrument, Inc., bioSyntagma, Inc., Calviri, Inc., Dignity Health, EthiX Associates, Exact Sciences, GT Medical Technologies, Inc., HonorHealth Research & Innovation Institute, Humabiologics, Inc., Langham Logistics, Inc., Mayo Clinic, Metfora, Microvascular Therapeutics, Navi Nurses, NuvOx Pharma, nVector, Plaza Companies, Regenesis Biomedical, Inc., Regional Center for Border Health, Inc.,
ReSuture Inc., SARRC, Scintillation Nanotechnologies, Inc., Sequitur Health Corp., SpencerFane, Translational Sciences, Inc.,
VMAS Solutions, Inc. (dba TouchPoint Solution), and Yelton and Associates.Continue reading
AdvaMed, 45 Health Organizations Call on Congressional Leaders to Pass VALID Act
WASHINGTON, D.C. – This week, the Advanced Medical Technology Association (AdvaMed), the world’s largest trade association representing medical device manufacturers, sent a letter urging House Energy and Commerce and Senate Health, Education, Labor and Pensions leaders to enact diagnostics reform provisions (The VALID Act) in the Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022.
Research Collaboration Informs International Classification of Firefighting as Carcinogenic
A long-time partnership between the Tucson Fire Department and researchers at the University of Arizona Health Sciences provided evidence that occupational exposure as a firefighter causes cancer.
Many studies, including several by the University of Arizona Health Sciences in collaboration with the Tucson Fire Department, contributed evidence that led the International Agency for Research on Cancer to determine occupational exposure as a firefighter causes cancer.Continue reading
MINDCROWD 2.0 LAUNCHES WITH NEW BRAIN GAMES, SMARTPHONE ACCESS
One-of-a-kind online study looks for ways to reduce cognitive decline as we age
COVID-19 VACCINATION ACTIVATES ANTIBODIES TARGETING PARTS OF VIRUS SPIKE PROTEIN SHARED BETWEEN CORONAVIRUSES
Technology developed by TGen researchers could help fine-tune future vaccinesContinue reading
Jacque Sokolov, MD named as one of the Directorship 100 by NACD
Jacque Sokolov, MD, CEO of SSB Solutions, was named as one of the Directorship 100 at an award ceremony in New York City on June 22, 2022. The Directorship 100 is a recognition of the most influential people in the boardroom and corporate governance community and is bestowed by the National Association of Corporate Directors (NACD)
The 2022 D100 comprises 50 directors and 50 governance professionals and institutions who exemplify the knowledge, leadership, and excellence NACD promotes. Awardees play a significant role in shaping the greater boardroom agenda.